Limiting infant exposure to thimerosal in vaccines and other sources of mercury

JAMA. 1999 Nov 10;282(18):1763-6. doi: 10.1001/jama.282.18.1763.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Hepatitis B Vaccines
  • Humans
  • Infant
  • Mercury Compounds* / adverse effects
  • Mercury Poisoning / prevention & control*
  • Preservatives, Pharmaceutical* / adverse effects
  • Thimerosal* / adverse effects
  • United States
  • United States Food and Drug Administration
  • Vaccination / standards
  • Vaccines* / adverse effects

Substances

  • Hepatitis B Vaccines
  • Mercury Compounds
  • Preservatives, Pharmaceutical
  • Vaccines
  • Thimerosal